β-Nicotinamide-Adenine Dinucleotide Phosphate, Reduced (β-NADPH)
β-Nicotinamide-Adenine Dinucleotide Phosphate, Reduced (β-NADPH) is a coenzyme useful for creatine, ammonia and urea reagents and the assessment of cytochrome P450 reductase activity. This NADPH is made by our parent Oriental Yeast Co., LTD in Japan, and inventories are available at our warehouse in California.
10 g, 50 g, 250 g, 1000 g
Formula / molecular Weight
UV Spectral Analysis
Ratios at pH 10.0A340/A260 (0.43 ± 0.02)ε at 260nm(14.4 ± 0.5) x 103ε at 340nm (6.2 ± 0.2) x 103
Our β-Nicotinamide-Adenine Dinucleotide Phosphate, Reduced (β-NADPH) is applicable for making Ammonia, Urinary Urea-Nitrogen (UUN), and Cholinesterase (ChE) reagents. It is also suitable for Cytochrome P450 Research and Biocatalysis. Additional products associated with these reagents include Glutamate Dehydrogenase (GLDH), and recombinant Urease (rUrease).
Short Term: ~ 5°C
Long Term: Below -20°C
Kowalski, J. P., McDonald, M. G., Whittington, D., Guttman, M., Scian, M., Girhard, M., Hanenberg, H., Wiek, C., & Rettie, A. E. (2019). Structure-Activity Relationships for CYP4B1 Bioactivation of 4-Ipomeanol Congeners: Direct Correlation between Cytotoxicity and Trapped Reactive Intermediates. Chemical research in toxicology, 32(12), 2488–2498. https://doi.org/10.1021/acs.chemrestox.9b00330
Fujino, C., Kuzu, T., Kubo, Y., Hayashi, K., Ueshima, S., & Katsura, T. (2023). Attenuation of phenobarbital‐induced cytochrome P450 expression in carbon tetrachloride‐induced hepatitis in mice models. Biopharmaceutics & Drug Disposition.